Enhanced airway smooth muscle (ASM) contraction is an important component in the pathophysiology of asthma. We have shown that ligand gated chloride channels modulate ASM contractile tone during the maintenance phase of an induced contraction, however the role of chloride flux in depolarization-induced contraction remains incompletely understood. To better understand the role of chloride flux under these conditions, muscle force (human ASM, guinea pig ASM), peripheral small airway luminal area (rat ASM) and airway smooth muscle plasma membrane electrical potentials (human cultured ASM) were measured. We found ex vivo guinea pig airway rings, human ASM strips and small peripheral airways in rat lungs slices relaxed in response to niflumic acid following depolarization-induced contraction induced by K(+) channel blockade with tetraethylammonium chloride (TEA). In isolated human airway smooth muscle cells TEA induce depolarization as measured by a fluorescent indicator or whole cell patch clamp and this depolarization was reversed by niflumic acid. These findings demonstrate that ASM depolarization induced contraction is dependent on chloride channel activity. Targeting of chloride channels may be a novel approach to relax hypercontractile airway smooth muscle in bronchoconstrictive disorders.
Enhanced airway smooth muscle (ASM) contraction is an important component in the pathophysiology of asthma. We have shown that ligand gated chloride channels modulate ASM contractile tone during the maintenance phase of an induced contraction, however the role of chloride flux in depolarization-induced contraction remains incompletely understood. To better understand the role of chloride flux under these conditions, muscle force (human ASM, guinea pig ASM), peripheral small airway luminal area (rat ASM) and airway smooth muscle plasma membrane electrical potentials (human cultured ASM) were measured. We found ex vivo guinea pig airway rings, human ASM strips and small peripheral airways in rat lungs slices relaxed in response to niflumic acid following depolarization-induced contraction induced by K(+) channel blockade with tetraethylammonium chloride (TEA). In isolated human airway smooth muscle cells TEA induce depolarization as measured by a fluorescent indicator or whole cell patch clamp and this depolarization was reversed by niflumic acid. These findings demonstrate that ASM depolarization induced contraction is dependent on chloride channel activity. Targeting of chloride channels may be a novel approach to relax hypercontractile airway smooth muscle in bronchoconstrictive disorders.
Asthma remains a global healthcare challenge with recent estimates citing an incidence of
8.2% of the US population in 2009 (1). Although
β-agonists remain the mainstay of treatment for acute bronchoconstriction, desensitization
to these drugs occurs and concerns remain as to whether the use of long acting β-agonists
are associated with increased asthma related deaths (2). In fact, the recent FDA-mandated review of these drugs underscores the pressing
need for new therapeutic approaches to treat this disease.One such potential therapeutic strategy involves targeting ion channels that may influence
airway smooth muscle force generation and/or maintenance of contractile tone. One particular
class of ion channel that is a promising candidate for such targeting is the chloride
channel. While a few seminal studies have established electrophysiologic evidence that
chloride channels play an important role in plasma membrane currents (3, 4) the role of these channels in
the maintenance of a depolarized-induced contraction in central and peripheral airways
remains unknown. This is an important clinical consideration, since most rescue therapies
(e.g. β-agonists) for the treatment of bronchospasm are typically administered after the
airway smooth muscle has already contracted and are directed at relieving pre-existing
bronchoconstriction.Furthermore, when considering the relevance of chloride channels to the pathophysiology of
acute bronchoconstriction two other critical questions remain. The first is the functional
relevance of chloride modulation in small peripheral airways since these smaller caliber
airways play an important clinical role in humanbronchoconstrictive disease and all prior
functional studies focusing on chloride flux have only been performed in large, upper airway
segments (5). Given the well-established observation
that receptor/channel expression can differ greatly between larger proximal airway and
smaller peripheral airway segments (6) the effects of
chloride modulation in proximal airway tissues may not be relevant to small airways. The
second concern we sought to address in this study was the applicability of these findings to
human physiology, since all prior studies did not include evidence of functional relevance
in intact human airway smooth muscle.As a result of these considerations, the current study addresses the hypotheses that
chloride channels are critical to the maintenance phase of an airway smooth muscle
contraction and that chloride channel blockade can relax depolarization-induced
pre-contracted guinea pig and human airway smooth muscle. Furthermore, in addition to
corroborating our findings in human cells and tissues, we hypothesized that the beneficial
functional effects of chloride blockade are preserved in small peripheral airways.
Materials and Methods
Cell culture
Cultures of immortalized human airway smooth muscle cells were a kind gift from Dr.
William Gerthoffer (Univ. of S. Alabama) and have previously been characterized (7). The cells were grown to confluence in 96-well
black-walled clear bottom plates for fluorescent FLIPR membrane potential assays. For
electrophysiology studies, cells were grown in 25 cm2 flasks that were
pre-coated with collagen (rat tail collagen type 1, 5 µg/cm2). All cells were
maintained in M199 media supplemented with 10% fetal bovine serum, 0.25 µg/ml epidermal
growth factor, 1 µg/ml fibroblast growth factor, ITS supplement (1 mg/ml insulin,
0.55 mg/ml transferrin, 0.67 µg/ml sodium selenium) and antibiotics (100 un/ml penicillin
G sodium, 100 µg/ml streptomycin sulfate, 0.25 µg/ml amphotericin B) at 37 °C in 5%
CO2-95% air as described (7).
Membrane potential measurements using fluorescent potentiometric probe
(FLIPR)
The membrane potential effects of tetraethylammonium chloride (TEA) and niflumic acid
were assessed using the FLIPR membrane potential assay. Human airway smooth muscle cells
were grown to 100% confluency in 96 well black-walled clear bottom plates. Protocols for
dye loading and cell preparations were previously described (8). The cell fluorescence changes were assessed using a Flexstation 3
microplate reader (Molecular Devices, Carlsbad, CA) using settings previously described
(9). Briefly the cells were washed and incubated
with 50% blue FLIPR dye and placed in the Flexstation. 100 μM NS1619 (a control potassium
channel opener causing hyperpolarization), 40 mM KCl (a control depolarizing agent), 100
μM niflumic acid or 10 mM TEA or buffer were added using the Flexstation's automated
injector at single concentrations while fluorescence was continuously measured at a rate
of 1 reading every 2 sec for a duration of 10 min and data were expressed as changes in
relative fluorescent units (ΔRFU) of the FLIPR dye.
Membrane potential measurements using electrophysiologic whole cell
recordings
Immortalized human airway smooth muscle cells were grown to confluence on
collagen-treated T25 flasks. Collagenase type IV in basal SmBM2 medium was used to release
adherent cells from the collagen matrix in the flask. Cells in media were then harvested
in a 10-ml conical tube and centrifuged at 300 × g. Supernatant was
removed, and the pellet was resuspended in additive-free SmBM2 media and transferred into
collagen-treated glass bottom 1 cm Petri dishes at 10% confluence. Each dish was then
incubated at 37 °C 5% CO2 for 1–4 h to allow for reattachment of cells to
glass-bottom Petri dishes (serving as a disposable recording chamber). ALA VM-8, (ALA,
Farmingdale, NY, USA) an 8-chamber pressure-driven drug application system, was used in a
still bath of extracellular salt solution. Whole-cell intracellular voltage recordings
under current clamp conditions were performed with a 2-kHz Bessel filter, recording at 10
kHz using an Axopatch 200b amplifier (Axon Instruments, Foster City, CA, USA).
Intracellular solutions consisted of (in mM): 140 KCl, 5 MgATP, 5 EGTA, 1
MgCl2, 10 HEPES, and 5 CaCl2 (pH 7.2). Extracellular solution
consisted of (in mM): 134 NaCl, 1.4 KCl, 10 HEPES, 1 MgCl2, 1.8
CaCl2, and 10 glucose (pH 7.4). Electrodes were pulled using a P-97
micropipette puller from 1.5-mm OD borosilicate capillary glass (Sutter Instruments,
Novato, CA, USA). Glass electrode resistances ranged from 5 to 10 MΩ with intracellular
solution. All recordings were analyzed on Clampfit 8.0 software (Molecular Devices).
Isolation of smooth muscle from human trachea and guinea pig trachea
All human airway tissue protocols were reviewed by the Columbia University Institutional
Review Board and were deemed not human subjects research under 45 CFR 46. Human tracheal
tissue was obtained from discarded airway tissue from healthy lung donors during
transplantation surgery at Columbia University. All guinea pig protocols were approved by
the Columbia University Institutional Animal Care and Use Committee. Guinea pigs were
deeply anesthetized with 100 mg/kg i.p. pentobarbital. Excision and dissection protocols
of tracheal tissue were previously described (8).
Briefly both human and guinea pig airways were dissected removing both extra-luminal
fibrous tissue and intraluminal epithelial tissue.
Functional studies of airway smooth muscle
Two contiguous, closed guinea pig tracheal ring segments (epithelium-denuded) were
suspended at 1 g resting tension in oxygenated Kreb-Henseleit buffer at 37 °C as
previously described (8). Kreb-Henseleit buffer
consisted of 140 mM NaCl / 4.7 mM KCl / 2.5 mM CaCl2 / 1.2 mM MgCl2
/ 11 mM HEPES / 10 mM d-glucose at a pH of 7.4. Human tracheal smooth muscle strips
(epithelium denuded) containing cartilaginous ends with a strip of airway smooth muscle
were suspended at 1.5 g resting tension in oxygenated Kreb-Henseleit buffer at 37 °C as
previously described (8). Pre-treatments,
pre-contraction protocols and the organ bath set up for human and guinea pig have been
previously described (8). Briefly, both human and
guinea pig airways were tied under tension to an FT03 transducer (Grass Telefactor,
Warwick, RI, USA) while tension was continuously digitally recorded. Smooth muscle was
contracted with 10 mM TEA and following the attainment of a stable contraction tissues
were treated with either vehicle (DMSO 0.1%, ethanol 0.1%), niflumic acid (100 μM), or
5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB) (Tocris, Bristol, UK) (100 μM) at 45
or 60 min after TEA for guinea pig or human airway smooth muscle, respectively.
Measurement of airway luminal area in rat lung slices
The Texas Tech University Health Sciences Center Institutional Animal Care & Use
Committee (IACUC) approved the rat animal studies. Rat lung slices were prepared following
a modification of a protocol for the preparation of mouse lung slices (10). Briefly, Charles River Sprague-Dawley rats
(180–320 g) were euthanized with i.p. sodium pentobarbital (Fatal Plus, 40 mg/kg) and
transferred to a clean dissection board in a dedicated sterile environment. Each animal
was rinsed with 90% ethanol, the chest cavity opened, and the trachea exposed and
cannulated with an intravenous (IV) catheter tube. The lungs were inflated with a warm
solution of 2% agarose (low-melting temperature agarose) (USB Corporation, Santa Clara,
CA, USA) in sterile Hank's balanced salt solution (sHBSS) by slowly injecting
approximately 5.0 ml of agarose solution per 100 g of body weight followed by 2.5 ml of
air. The air injection was used to flush the agarose out of the airways and into the
distal alveolar space. The agarose was solidified by cooling the lungs with a cotton ball
soaked in ice-cold sHBSS and maintaining the rat body temperature at 4 °C for 20 min. The
lungs and heart were removed from the animal and held in ice-cold sHBSS for 15 min. The
left lung was separated and trimmed near the main bronchus and along the long axis to
create a base and then cut in three pieces. Each piece was transferred to the specimen
syringe tube of a tissue slicer (Compresstome™ VF-300, Precisionary Instruments, San Jose,
CA, USA) with the lobe base sitting on the tube. The lung lobe was embedded first into ∼1
ml 2% agarose and then fully covered with 6% gelatin. After the agarose and gelatin
solidified, the block was cut into serial sections of 150 µm starting at the peripheral
edge of the lung lobe. The entire procedure was performed in a safety cabinet under
sterile conditions. Lung slices were observed on an inverted phase-contrast microscope and
checked for the presence of airways. The first few slices usually lacked well-defined
airways and were discarded. The subsequent 15–20 slices containing small terminal airways
were collected and stored briefly in sHBSS. The slices were then incubated in low-glucoseDulbecco's Modified Eagle Medium supplemented with 1X antibiotic solution containing
L-glutamine, penicillin and streptomycin and 50 µg/ml of gentamicin at 37 °C and 10%
CO2 in a cell culture incubator. Lung slices were maintained for 8 to 48 h;
no significant changes in airway contractility in response to 0.5 µM acetylcholine (ACh)
were detected during this period. For experiments we only used lung slices that contained
airways with a lumen diameter of 200–300 µm, completely lined by active ciliated
epithelial cells, and fully attached to the surrounding lung parenchyma.
Measurement of small airway contraction
Airway contraction and relaxation was accessed in rat lung slices by calculating the
changes in the airway cross-sectional luminal area (lumen area hereafter) using
phase-contrast video microscopy as previously described (10). Briefly, rat lung slices were mounted in a custom-made perfusion chamber
and held in place with a small sheet of nylon mesh. The lung slice was perfused
continuously with sHBSS or the indicated experimental solutions. The chamber was placed on
the stage of an inverted phase-contrast microscope (Diaphot TMD, Nikon Melville, NY, USA)
and lung slices were imaged with a 10× objective. Digital images were recorded to a hard
drive in time-lapse (0.5 Hz) using a CCD camera and image acquisition software (Video
Savant™, IO Industries London, Ontario, Canada). The cross-sectional area the airway lumen
was calculated from each image using a custom-written script in Video Savant. The lumen
area was normalized to the area before stimulation and the changes in lumen area were
plotted versus time. All experiments were performed at room temperature.
Materials
SmBM2 cell culture media was purchased from Lonza (Walkersville, MD, USA). All other cell
culture reagents were purchased from Invitrogen (Grand Island, NY, USA). The blue FLIPR
reagent was purchased from Molecular Devices. All other reagents were purchased from
Sigma-Aldrich (St. Louis, MO, USA) unless otherwise indicated.
Statistical analysis
Fluorescent potentiometric studies (FLIPR assays), relaxation of contractile force in
organ bath and measurement of changes in luminal area in rat peripheral lung slices were
analyzed by ANOVA with Bonferroni correction. Statistical significance was established at
P<0.05 and all values are expressed as means ± S.E.M.
Results
Membrane potential changes in human airway smooth muscle cells following niflumic
acid and TEA
In order to confirm that 10 mM TEA (a non-selective potassium channel blocker)
depolarizes airway smooth muscle and to compare the magnitude to the depolarization
induced by KCl, a potentiometric fluorescent probe was used to measure the membrane
potential during 10 mM TEA and 40 mM KCl treatments. Furthermore, to demonstrate that 100
μM niflumic acid hyperpolarizes airway smooth muscle its effect was compared to a positive
control, 10 μM NS1619 (a K+ channel opener known to hyperpolarize the plasma
membrane). 10 mM TEA and 40 mM KCl caused an increase in fluorescence change consistent
with membrane depolarization (152 ± 16.6 and 195 ± 11.8 maximum ΔRFU, respectively)
(P<0.001 compared to buffer control). 100 μM niflumic acid and
NS1619 demonstrated directional congruency as hyperpolarizing agents with a decrease in
fluorescence (–195 ± 22 and –341 ± 37 maximum ΔRFU (P<0.01 and
P<0.001 compared to buffer control respectively).
(n=4–12) (Fig. 1).
Fig. 1.
Plasma membrane potential in human airway smooth muscle. Left:
Representative tracings of real-time FLIPR potentiometric dye fluorescence emissions
after cultured human airway smooth muscle cells were treated with either buffer, 100
μM niflumic acid, 40 mM KCl, 10 mM TEA or 10 μM NS1619. These tracings display
directionality of the fluorescence change in relation to depolarization (upward
deflection: TEA, KCl) and hyperpolarization (downward deflection: niflumic acid,
NS1619). Right: FLIPR potentiometric dye fluorescence emissions
(RFU), measures at maximum change values, after cultured airway smooth muscle cells
were treated with either buffer (control), 40 mM KCl, 10 μM NS1619, 100 μM niflumic
acid or 10 mM TEA. * P<0.01 for niflumic (–195 ± 22 maximum
ΔRFU) (n=11); ** P<0.001 for NS1619 (–341 ±
37.7 maximum ΔRFU), TEA (152 ± 16.6 maximum ΔRFU) or KCl (195 ± 20.5 maximum ΔRFU)
compared to control (n=4).
Plasma membrane potential in human airway smooth muscle. Left:
Representative tracings of real-time FLIPR potentiometric dye fluorescence emissions
after cultured human airway smooth muscle cells were treated with either buffer, 100
μM niflumic acid, 40 mM KCl, 10 mM TEA or 10 μM NS1619. These tracings display
directionality of the fluorescence change in relation to depolarization (upward
deflection: TEA, KCl) and hyperpolarization (downward deflection: niflumic acid,
NS1619). Right: FLIPR potentiometric dye fluorescence emissions
(RFU), measures at maximum change values, after cultured airway smooth muscle cells
were treated with either buffer (control), 40 mM KCl, 10 μM NS1619, 100 μM niflumic
acid or 10 mM TEA. * P<0.01 for niflumic (–195 ± 22 maximum
ΔRFU) (n=11); ** P<0.001 for NS1619 (–341 ±
37.7 maximum ΔRFU), TEA (152 ± 16.6 maximum ΔRFU) or KCl (195 ± 20.5 maximum ΔRFU)
compared to control (n=4).
Membrane potential changes of TEA and niflumic acid measured by single cell voltage
recordings
To confirm the effects of TEA and niflumic acid on plasma membrane potential of smooth
muscle cells using traditional electrophysiologic whole cell patch clamp techniques, whole
cell current clamp recordings of individual airway smooth muscle cells were performed. The
average resting membrane potential was –56.4 ± 6.5 mV (n=3) (Fig. 2, Table 1 ). Exposure to TEA (10 mM) depolarized the plasma membrane (Fig. 2, Table
1). Following a plasma membrane depolarization with TEA, the addition of 100 μM
niflumic acid resulted in a complete reversal of the depolarization back to membrane
potentials near baseline resting values (Fig. 2,
Table 1).
Fig. 2.
Airway smooth muscle whole cell electrical recording of membrane potential. A
representative tracing of voltage recordings in a cultured human airway smooth
muscle cell under current clamp in a single whole cell recording. Resting membrane
potential was –56.4 ± 6.5 mV (n=3). 10 mM TEA depolarized cultured
human airway smooth muscle cells and 100 μM niflumic acid treatment after 10 mM TEA
returned membrane potential to near baseline resting values
(n=3).
Table 1.
Membrane potentials of individual human airway smooth muscle cells
Treatment
Membrane potential (mV)
none
TEA
TEA + niflumic acid
Cell 1
-58.1
-16.3
-60.6
Cell 2
-45.7
-34.0
-39.8
Cell 3
-68.2
-37.6
-81.4
Airway smooth muscle whole cell electrical recording of membrane potential. A
representative tracing of voltage recordings in a cultured human airway smooth
muscle cell under current clamp in a single whole cell recording. Resting membrane
potential was –56.4 ± 6.5 mV (n=3). 10 mM TEA depolarized cultured
human airway smooth muscle cells and 100 μM niflumic acid treatment after 10 mM TEA
returned membrane potential to near baseline resting values
(n=3).
Inhibitors of chloride channels directly relax depolarization-induced contractions in
guinea pig airway smooth muscle
To investigate the role of chloride channels in depolarization induced contractions, we
initially contracted guinea pig tracheal rings in an organ bath using 10 mM TEA. TEA
induces a reliable and consistent contraction in both human and guinea pig airway smooth
muscle. To demonstrate that chloride channel inhibition can relax an established TEA
mediated airway smooth muscle contraction, niflumic acid was added to the buffer in organ
baths after the contracted muscle force of guinea pig tracheal rings had reached a stable
plateau of increased force. To complement these studies, a second structurally distinct
pharmacologic inhibitor of chloride channels, 5-nitro-2-(3-phenylpropylamino) benzoic acid
(NPPB), was also evaluated. Guinea pig tracheal rings treated with 100 μM niflumic acid or
100 μM NPPB demonstrated a significant decrease in muscle force measured at 30 min after
their addition (36.1 ± 8.8% and 59.8 ± 5.8%, respectively), compared to the original
TEA-induced force (P<0.001). Vehicle controls (0.1% ethanol for
niflumic acid and 0.1% DMSO for NPPB) were without significant effect (108 ± 3.2% and 109
± 5.1%, respectively) over the same time period (Fig.
3) (n=4–6).
Fig. 3.
TEA induced contractions of guinea pig airway smooth muscle are relaxed by
chloride channel blockers NPPB and niflumic acid. Left:
Representative tracings of guinea pig tracheal rings contracted with 10 mM TEA with
the addition of either vehicle controls (0.1% ethanol or 0.1% DMSO) or chloride
channel antagonists. A and B, the gray bars represent the 45 min time point when
treatments were applied. The associated muscle force at the time of treatment is
also noted as 1.04 and 0.99 grams, respectively. C and D, the gray bars represent
the 60 min time point when treatments were applied. The associated muscle force at
the time of treatment is also noted as 1.04 and 0.88 grams respectively.
Right: Muscle force expressed as a percent of the plateau
TEA-induced contraction. Airway smooth muscle demonstrated a significant reduction
in muscle force 30 mins after treatment with 100 μM niflumic acid
(n=6) (36.1 ± 8.8% of the initial TEA-induced force)
(**P< 0.001 compared to ethanol control). Airway smooth muscle
demonstrated a significant reduction in muscle force 30 mins after treatment with
100 μM NPPB (n=6) (59.8 ± 5.8% of the initial TEA-induced force at
30 min) (**P< 0.001 compared to DMSO control). Thirty minutes
after treatment with ethanol (n=6) or DMSO (n=4) vehicles the
resulting muscle force was not significantly different from the initial TEA-induced
force (108 ± 3.2% and 109 ± 5.1%, respectively).
TEA induced contractions of guinea pig airway smooth muscle are relaxed by
chloride channel blockers NPPB and niflumic acid. Left:
Representative tracings of guinea pig tracheal rings contracted with 10 mM TEA with
the addition of either vehicle controls (0.1% ethanol or 0.1% DMSO) or chloride
channel antagonists. A and B, the gray bars represent the 45 min time point when
treatments were applied. The associated muscle force at the time of treatment is
also noted as 1.04 and 0.99 grams, respectively. C and D, the gray bars represent
the 60 min time point when treatments were applied. The associated muscle force at
the time of treatment is also noted as 1.04 and 0.88 grams respectively.
Right: Muscle force expressed as a percent of the plateau
TEA-induced contraction. Airway smooth muscle demonstrated a significant reduction
in muscle force 30 mins after treatment with 100 μM niflumic acid
(n=6) (36.1 ± 8.8% of the initial TEA-induced force)
(**P< 0.001 compared to ethanol control). Airway smooth muscle
demonstrated a significant reduction in muscle force 30 mins after treatment with
100 μM NPPB (n=6) (59.8 ± 5.8% of the initial TEA-induced force at
30 min) (**P< 0.001 compared to DMSO control). Thirty minutes
after treatment with ethanol (n=6) or DMSO (n=4) vehicles the
resulting muscle force was not significantly different from the initial TEA-induced
force (108 ± 3.2% and 109 ± 5.1%, respectively).
An inhibitor of chloride channels directly relaxes depolarization-induced
contractions in human airway smooth muscle
To demonstrate that chloride channel inhibition can relax a TEA mediated contraction in
human airway smooth muscle, niflumic acid was added to the buffer in organ baths after
human airway strips reached a plateau of muscle force induced by TEA. Niflumic acid
decreased airway smooth muscle tension to 29% ± 9.7% of the initial TEA-induced force at
30 min (P<0.001 compared to 0.1% ethanol vehicle control). Ethanol
vehicle treated airway smooth muscle strips did not demonstrate a significant change in
muscle force over the same time period (Fig.
4) (n=6).
Fig. 4.
TEA induced contractions in human airway smooth muscle are relaxed by the chloride
channel blocker niflumic acid. Left: Representative tracings of
human tracheal strips muscle force with the addition of TEA and subsequently treated
with either ethanol vehicle control or 100 μM niflumic acid. A and B, the gray bars
represent the 45 min time point when treatments were applied. The associated muscle
force at the time of treatment is also noted as 0.43 and 0.58 grams, respectively.
Right: Muscle force expressed as a percent of plateau TEA-induced
contraction. Human airway smooth muscle demonstrated a significant reduction in
TEA-induced muscle force at 30 min after the addition of 100 μM niflumic acid
(n=6) (29.6 ± 9.7% of the initial TEA-induced force) (**
P<0.001 compared to ethanol control). Thirty minutes after
treatment with ethanol vehicle (n=6) the resulting muscle force was
not significantly different from the initial TEA-induced force (101 ± 1.9%).
TEA induced contractions in human airway smooth muscle are relaxed by the chloride
channel blocker niflumic acid. Left: Representative tracings of
human tracheal strips muscle force with the addition of TEA and subsequently treated
with either ethanol vehicle control or 100 μM niflumic acid. A and B, the gray bars
represent the 45 min time point when treatments were applied. The associated muscle
force at the time of treatment is also noted as 0.43 and 0.58 grams, respectively.
Right: Muscle force expressed as a percent of plateau TEA-induced
contraction. Human airway smooth muscle demonstrated a significant reduction in
TEA-induced muscle force at 30 min after the addition of 100 μM niflumic acid
(n=6) (29.6 ± 9.7% of the initial TEA-induced force) (**
P<0.001 compared to ethanol control). Thirty minutes after
treatment with ethanol vehicle (n=6) the resulting muscle force was
not significantly different from the initial TEA-induced force (101 ± 1.9%).
An inhibitor of chloride channels directly relaxes depolarization-induced
contractions in rat bronchioles
To demonstrate that TEA induced potassium channel blockade can induce a sustained
contraction in smaller airways and to show that this mechanism is conserved between
species, rat lung slices were exposed to TEA in a tissue chamber and airway luminal areas
were quantified by continuous digital video. 10 mM TEA reduced luminal area comparable to
the classical contractile agonists 50 mM KCl and 100 nM ACh (Fig. 5A, 5B). Additionally niflumic acid 100 μM added during the sustained contractile phase of
TEA showed direct relaxation (Fig. 5C).
Consistent with a contraction, 10 mM TEA treated bronchioles showed a 64.2% ± 7.9%
reduction in luminal area. The magnitude of this contractile response was significantly
attenuated by 100 μM niflumic acid, diminishing the reduction in luminal area to 7.9% ±
2.6% percent of its original baseline area (n=4,
P<0.01) (Fig. 5C).
Fig. 5.
Rat lung slice luminal area measurements. A) Representative images of video
recorded rat lung slices. Images (1)–(4) correlate to graphically represented luminal
area tracing demarcated by arrows ()–(4) in panel B. Photograph (1) is a rat bronchiole without treatment. Photograph (2) is the same rat bronchiole treated with 100 nM
ACh. Photograph (3) is the same rat bronchiole
after a buffer wash and treated with 50 mM KCl. Photograph (4) is the same rat bronchiole after a buffer wash and treated with
10 mM TEA. B) Left: A representative tracing of bronchiolar luminal
area extracted from video recorded images expressed as a percent of baseline luminal
area (denoted by (1)). Right:
Airway luminal area was measured as a percentage of baseline luminal areas at points
(2), (3) and (4). (n=5
for all groups). Mean intraluminal area values of TEA was not significantly
different between ACh and KCl groups (n=5,
P>0.05). C) Left: A representative tracing of
bronchiolar luminal area measurements showing niflumic acid (NFA) direct relaxation
of TEA contraction. Right: Airway luminal area as a percentage of
baseline luminal area at points before and after niflumic acid were significantly
different (n=4, *P<0.01).
Rat lung slice luminal area measurements. A) Representative images of video
recorded rat lung slices. Images (1)–(4) correlate to graphically represented luminal
area tracing demarcated by arrows ()–(4) in panel B. Photograph (1) is a rat bronchiole without treatment. Photograph (2) is the same rat bronchiole treated with 100 nM
ACh. Photograph (3) is the same rat bronchiole
after a buffer wash and treated with 50 mM KCl. Photograph (4) is the same rat bronchiole after a buffer wash and treated with
10 mM TEA. B) Left: A representative tracing of bronchiolar luminal
area extracted from video recorded images expressed as a percent of baseline luminal
area (denoted by (1)). Right:
Airway luminal area was measured as a percentage of baseline luminal areas at points
(2), (3) and (4). (n=5
for all groups). Mean intraluminal area values of TEA was not significantly
different between ACh and KCl groups (n=5,
P>0.05). C) Left: A representative tracing of
bronchiolar luminal area measurements showing niflumic acid (NFA) direct relaxation
of TEA contraction. Right: Airway luminal area as a percentage of
baseline luminal area at points before and after niflumic acid were significantly
different (n=4, *P<0.01).Digital video recordings of single bronchioles contracting and relaxing were obtained.
The bronchiole within the lung slice was treated with contractile agonists; 100 nM ACh,
50 mM KCl and 10 mM TEA. Contractions were recorded and HBSS was used to washout the
contractile agonist which correlates with smooth muscle relaxation between the contractile
challenges (see supplemental video available at the Journal website).
Discussion
The major finding of this study is that functional relaxation of an established
depolarization-induced contraction is achieved by chloride channel blockade. It should be
noted that this is the first demonstration of this effect in intact human tissues taken from
proximal tracheal and first generation bronchial ring preparations. While other
investigators have shown that drugs targeting chloride channels are capable of modulating
ionic currents, electrical slow waves and airway smooth muscle force generation (3,4,5), their studies have been limited to non-human models
and primarily focused on the initiation phase of airway smooth muscle contraction since the
drugs were administered before the contractile agonist. In this manuscript we have expanded
our experimental model to examine the effect of chloride channel blockade on pre-contracted
airway smooth muscle, since most therapeutic interventions used to treat acute
bronchoconstriction rely on relaxing established tone (i.e. β agonists). Therefore, the
current group of studies extends our knowledge about how chloride flux functions to modulate
the maintenance phase of an airway smooth muscle contraction. Additionally, we demonstrate
correlative changes by electrophysiology and potentiometric dyes that illustrate for the
first time in human cells the ability of these chloride channel antagonists to reverse
TEA-induced depolarization. Lastly, we validate that chloride channel blockade also achieves
relaxation of smooth muscle in peripheral lung sections with real-time video of a
bronchiolar TEA-induced contraction. This is an important distinction since diseases like
asthma are thought to involve small airways and differential receptor expression is known to
occur between proximal and distal airways (6).While the relative importance of electromechanical coupling in airway smooth muscle has
been controversial, recent evidence demonstrates that proteins critical to airway smooth
muscle contraction are indeed influenced by membrane potential. At the plasma membrane,
voltage changes have been shown to influence muscarinic, G-protein coupled receptors by
increasing the binding affinity of ACh (11). Recently
the mechanism of bitter taste receptor mediated airway smooth muscle relaxation has been
attributed to blockade of voltage sensitive calcium channels (12). Intracellularly, membrane potential has been shown to induce
agonist-independent M3 muscarinic receptor generation of IP3 in vascular smooth
muscle (13). Rho kinase activity, a protein that
regulates myosin light chain phosphorylation, is enhanced by plasma membrane depolarization,
thereby linking membrane potential to increases in activated myosin (14, 15). Finally, at the organelle
level, ryanodine- and IP3-receptor mediated calcium release has been shown to be
augmented by airway smooth muscle depolarization (16). Thus, plasma membrane electrical potential and classic second messenger control
of calcium may not operate in isolation.As mentioned, a central observation in this study was the ability of chloride channel
blockade afforded by niflumic acid to relax a TEA induced contraction. We chose TEA as a
contractile agonist because it allowed us to compare its functional effects in the organ
bath with known electrophysiologic effects. TEA also allows for the study of the effect of
membrane depolarization on contractile tone in isolation, devoid from the complex
second-messenger signaling events that accompany classic G protein coupled contractile
pathways (i.e. ACh, histamine, substance P, leukotrienes). TEA (a non-selective potassium
channel blocker) was specifically chosen over KCl as an effective agonist of airway smooth
muscle contraction. One rationale for using TEA is that KCl creates a high potassium
gradient to suppress potassium flux, which essentially never occurs in normal or pathologic
physiology. In contrast, TEA mimics a more physiologic depolarization via blockade of
endogenous potassium channels. Potassium channel inhibition and modulation occurs in
physiologic and pathologic conditions. One example is the phosphorylation of the potassium
channel by G protein coupled receptors, which has been described as a function of the
M2 receptor on airway smooth muscle (17). Secondly, mutations associated with certain types of asthma occur in certain
potassium channel families that have been described as inhibitory towards normal potassium
channel function (18). If TEA induced contractions
act as a model for these naturally occurring phenomena then chloride flux may have an
influential role on the contractile response in normal and possibly diseased tissues.
Furthermore, TEA is important because of its effects on membrane potential that has been
associated with changes in baseline tone and spontaneous force oscillation (3). Previous studies demonstrated that TEA-induced
increases in spontaneous electrical slow wave in airway smooth muscle were abolished by
chloride channel blockade with niflumic acid (3).
These findings agree with our current tension studies indicating that niflumic acid inhibits
both spontaneous slow waves and myogenic tone, and that chloride flux plays a key role in
electromechanical coupling.Additionally, our present study shows that TEA increases membrane potential of a single
cell by approximately 30 mV which agrees with previous studies (19). Moreover, we extend the electrophysiologic characterization of human
airway smooth muscle cells by demonstrating that niflumic acid induces a relative
hyperpolarization following this TEA-induced depolarization. While this phenomenon was not
observed in every cell studied, it was observed in the majority of cells studied (60%). This
raises the question as to whether there are differential electrophysiologic characteristics
between individual smooth muscle cells within the airway. It should be noted that
electrophysiologic differences among a population of airway smooth muscle cells has been
described before and may allude to a electrophysiologic heterogeneity in airway smooth
muscle cells that has not yet been fully appreciated.While airway smooth muscle is classically thought to be a uniform syncytium, evidence does
exist that supports the possibility that individual muscle cells display distinct
electrophysiologic properties. Janssen and Simms demonstrated in the same study that ACh
elicited transient inward current oscillations in one group of cells, while in other cells
ACh elicited a single large slowly rectifying inward current, suggesting different channel
activity or expression in these different cells (20).
Furthermore, in another study of primary disassociated airway smooth muscle cells, some
cells demonstrated spontaneous transient inward and outward currents while other cells
demonstrated only spontaneous transient outward currents while others were
electrophysiologically quiescent at resting membrane potential (3, 19). Furthermore, in
vivo spontaneous electrical and peristaltic contractile activity of developing
airway smooth muscle is critical to lung bud development. The origin of this spontaneous
electrical signal appears to be in sub-specialized cells of airway smooth muscle beds (21).The current study demonstrates the ability of niflumic acid to relax the maintenance phase
of a depolarization-induced contraction in large and small airways of multiple species,
including human. Although airway hyperresponsiveness is complex, and does not depend solely
on membrane depolarization, improving our understanding of the role of membrane potential
and chloride flux in airway smooth muscle contraction may expand our therapeutic options for
hypercontractile airway smooth muscle.
Conflict of interest
The authors declare that they have no conflict of interest.Digital video recording of single bronchiole constriction. A representative digital video recording of a single bronchiole during luminal airway
measurements. Treatments shown in figure 5B (ACh 100 nM, KCl 50 mM and TEA 10 mM) were
exposed to a single bronchiole. The luminal areas were decreased, representing contraction
with each treatment, confirming a contractile response to all three agonists. Note, buffer
washes in between each contractile treatment, and that luminal areas return to baseline
size during buffer washes.
Authors: Qing-Hua Liu; Yun-Min Zheng; Amit S Korde; Vishal R Yadav; Rakesh Rathore; Jürgen Wess; Yong-Xiao Wang Journal: Proc Natl Acad Sci U S A Date: 2009-06-19 Impact factor: 11.205
Authors: Cheng-Hai Zhang; Lawrence M Lifshitz; Karl F Uy; Mitsuo Ikebe; Kevin E Fogarty; Ronghua ZhuGe Journal: PLoS Biol Date: 2013-03-05 Impact factor: 8.029
Authors: Kent Miner; Katja Labitzke; Benxian Liu; Paul Wang; Kathryn Henckels; Kevin Gaida; Robin Elliott; Jian Jeffrey Chen; Longbin Liu; Anh Leith; Esther Trueblood; Kelly Hensley; Xing-Zhong Xia; Oliver Homann; Brian Bennett; Mike Fiorino; John Whoriskey; Gang Yu; Sabine Escobar; Min Wong; Teresa L Born; Alison Budelsky; Mike Comeau; Dirk Smith; Jonathan Phillips; James A Johnston; Joseph G McGivern; Kerstin Weikl; David Powers; Karl Kunzelmann; Deanna Mohn; Andreas Hochheimer; John K Sullivan Journal: Front Pharmacol Date: 2019-02-14 Impact factor: 5.810
Authors: George Gallos; Gene T Yocum; Matthew E Siviski; Peter D Yim; Xiao Wen Fu; Michael M Poe; James M Cook; Neil Harrison; Jose Perez-Zoghbi; Charles W Emala Journal: Am J Physiol Lung Cell Mol Physiol Date: 2015-02-06 Impact factor: 5.464
Authors: Peter D Yim; George Gallos; Jose F Perez-Zoghbi; Yi Zhang; Dingbang Xu; Amy Wu; Dan E Berkowitz; Charles W Emala Journal: Am J Physiol Lung Cell Mol Physiol Date: 2018-10-04 Impact factor: 5.464